Insurers should consider the implications of a wider deployment of these drugs for treating a much broader range of dise…

Costly new drugs are proliferating.

Patented medicines make up approximately 47 per cent of all drug sales in Canada.

This includes out-of-pocket expenses and lost income.

Healthcare spending could rise to $9,054 per capita.

One in 20 Canadians report cost-related nonadherence.

Sufferers receive drastically different care depending on their home province or territory.